BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a sequence found in human gastric juice. Clinically it has attracted interest for soft-tissue repair, tendon and ligament recovery, and gut-lining support. It is not approved by the TGA — meaning it is not listed on the Australian Register of Therapeutic Goods — but it can be lawfully prescribed by a registered Australian doctor on a case-by-case basis through the Special Access Scheme, Category B (SAS-B).
The legal picture in plain English: you cannot buy BPC-157 over the counter, you cannot lawfully import it yourself as a "research chemical", and you cannot get it through a regular GP prescription bound to the ARTG. You can receive it via a TGA SAS-B notification lodged by an AHPRA-registered Australian doctor who has assessed you clinically, with the medicine compounded by a TGA-licensed Australian pharmacy.
Typical clinical use cases reviewed at consultation include chronic tendon issues that have failed conservative management (Achilles, patellar, rotator cuff), post-surgical soft-tissue recovery, and gut-related conditions where standard treatment has plateaued. BPC-157 is not a first-line therapy for anything — your doctor will look at what conventional treatment has been tried and whether SAS-B prescribing is clinically justified.
Free guide: Legal Peptides in Australia (2026)
What's legal under TGA SAS-B, which peptides Australian doctors actually prescribe, real costs, and the questions to ask at your consult.
No spam. Unsubscribe any time. See our privacy policy.
Administration is typically by subcutaneous injection, with dose, duration, and cycling decided by your prescriber based on the indication. Common reported side effects in the small body of published data are mild and transient (injection-site reactions, occasional nausea); however, long-term safety data in humans is limited, which is one of the reasons a doctor — not a website — should make the prescribing decision.
What to avoid: buying BPC-157 online from offshore vendors. The vials sold as "research peptides" carry no guarantee of identity, sterility, or potency, and importing them is an offence under the Customs Act. The Australian system is slower, but the vial you inject is traceable from active ingredient to compounding pharmacy to your name.
If you'd like to be assessed for BPC-157 specifically, start with our 5-minute intake. If you're suitable, you'll be matched with an AHPRA-registered Australian doctor who can decide whether SAS-B prescribing is clinically appropriate for your case.